期刊文献+

喜树碱抗肿瘤活性官能团E环的结构修饰研究进展

Advances in structural modification of the E ring in camptothecin as an anti-tumor functional group:A review
下载PDF
导出
摘要 喜树碱作为蓝果树科喜树Camptotheca acuminata Decne的重要活性成分,是一种广谱高效的抗肿瘤药物。但喜树碱水溶性差、无肿瘤靶向性、毒副作用强和E环结构不稳定等缺陷,使其临床应用受到了极大的限制。喜树碱E环是重要的抗肿瘤活性官能团,其含有一个六元内酯环结构,能够与抑制TopoI特异性结合,抑制TopoI活性。但E环在生理条件下易被水解开环而降低药物活性,且开环后的喜树碱钠盐具有严重的细胞毒性。本文对喜树碱E环的结构修饰研究进行综述,为将来基于喜树碱E环修饰类药物研发提供一定思路。 Camptothecin,an essential active ingredient of Camptotheca acuminata Decne,represents a broad-spectrum and the highly efficient antitumor drug.However,the clinical application of camptothecin is extremely limited due to its poor water solubility,the absence of tumor targeting,highly toxic side effects and the instability of the E ring structure.The E ring in camptothecin is a crucial antitumor active functional group consisting of a six-membered lactone ring structure and capable of specifically binding to and inhibiting Topo I activity.Nevertheless,the E ring is susceptible to hydrolysis under physiological conditions to open the ring and diminish the drug activity,and the ring-opened sodium salt of camptothecin has severe cytotoxicity.This review on the structural modification of the E ring is intended to facilitate the development of future drugs based on the derivation of the E ring of camptothecin.
作者 杨济瑞 鲁军 YANG Ji-Rui;LU Jun(School of Pharmacy,Chengdu University of Traditional Chinese Medicine,Chengdu 611137,Sichuan)
出处 《中药与临床》 2023年第3期94-99,共6页 Pharmacy and Clinics of Chinese Materia Medica
基金 国家自然科学基金(81803374,82273812) 成都中医药大学杏林学者研究促进项目(BJRC2020002)。
关键词 喜树碱 TOPOI 六元内酯环 细胞毒性 结构修饰 Camptothecin Topo I six-membered lactone ring cytotoxicity structural modification
  • 相关文献

参考文献1

二级参考文献12

  • 1潘显道,王存英.天然抗肿瘤药喜树碱衍生物的研究进展[J].药学学报,2003,38(9):715-720. 被引量:31
  • 2Wall ME, Wani MC, Cook CE, et al. Plant antitumor agent I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata [J]. J Am Chem Soc, 1966,88(16) :3888 -3890.
  • 3Wani MC, Nicholas AW, Wall ME. Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogues [ J ]. J Med Chem, 1986,29( 11 ) :2358 -2363.
  • 4Slichenmyer W J, Clin J. New natural products in cancer chemotherapy [ J ]. Pharmacology, 1990,30 ( 9 ): 770 -788.
  • 5Yaegashi T, Okata KN, Sawada S, et al. Chemical modification of an antitumor alkaloid, 20 (S)-camptothecin: glycosides, phosphates and sulfates of 7-ethyl-10-hydroxycamptothecin [ J]. Chem Pharm Bull,1992,40( 1 ): 131 - 135.
  • 6Hsiang YH, Hertzberg R, Hecht S, et al. Camptothecin induces protein linked breaks via mammalian DNA topoisomerase Ⅰ [ J ]. J Biol Chem, 1985,260 ( 27 ):14873 - 14878.
  • 7Sugimoto Y, Tsudahara S. Elevated expression of DNA topoisomerase Ⅱ in camptothecin resistant human tumor cell lines [ J ]. Cancer Res, 1990,50 (24) :7962 - 7965.
  • 8Robinson C, Robinson K, Castaner J. 9-Aminocamptothecin [J]. Drugs Future, 1996,21(9) :881-889.
  • 9Kumazawa E, Jimbo T, Ochi Y. Potent and broad antitumor effects of DX-895lf, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice [ J ]. Cancer Chemother Pharmacol, 1998,42 (3) :210 - 220.
  • 10Moreau P, Anizon F, Scancelme M, et al. Synthesis,mode of action, and biological activities of rebeccamycin bromo derivatives [ J ]. J Med Chem, 1999,42 (10):1816 - 1822.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部